$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group

(Chiang Mai, Thailand, 1993-1997 cases followed-up until 2000)

Click on cancer site (ICD-10 code) for comparison
SiteICD-10No. of casesMaleFemaleNumber of cases by age groupRelative survival by age group
5-year survival5-year survival
No.AbsRelNo.AbsRel<4545-5455-6465-7475+<4545-5455-6465-7475+
C01-02Tongue856114.716.02421.522.512914252519.70.028.018.30.0
C03-06Oral cavity1016016.718.14128.931.381331242531.432.520.99.935.5
C09Tonsil513917.918.712779151340.20.034.70.00.0
C11Nasopharynx1339331.332.54044.045.230323824941.163.436.76.10.0
C12-13Hypopharynx695623.225.113031726230.033.939.414.921.1
C15Oesophagus88565.86.23214.616.32132334160.017.05.56.023.8
C16Stomach31618013.714.713610.010.4484990874217.39.016.05.815.8
C18Colon23712631.633.411126.828.1453856683026.233.446.524.019.8
C19-20Rectum19010229.231.48826.227.6402241573029.637.730.428.523.3
C22Liver7054972.42.52085.35.6171138194150521.16.14.41.20.0
C23-24Gall bladder135508510.110.612152961180.00.08.27.50.0
C25Pancreas1064912.213.9579.39.610133136160.00.011.50.019.1
C26Gastrointestinal tract unspecified311813758560.00.00.00.00.0
C30-31Nose/Sinuses332133.134.21240.441.3103125360.00.032.50.00.0
C32Larynx15311630.933.7373.73.991036653333.837.518.229.828.3
C33-34Lung16429454.24.56975.05.310224863251614410.34.33.84.47.6
C40-41Bone352715.315.6844.645.124434029.30.00.00.00.0
C43Melanoma skin27141335.938.26349533.60.068.70.00.0
C44Other skin1698735.338.88247.451.8161436574683.046.279.242.316.1
C47+C49Connective tissue451944.847.02645.146.123865346.20.043.740.638.5
C50Breast5442100.0101.754260.661.922216491452270.663.056.631.550.3
C51Vulva282836.439.42561050.072.363.30.075.2
C53Cervix88588558.860.2360215183973064.063.260.244.834.6
C54Corpus uteri989866.267.925243512286.378.062.841.50.0
C56Ovary16216247.147.969423016561.150.731.90.00.0
C60Penis727232.034.62110161690.00.036.361.30.0
C61Prostate10710730.434.9051843410.040.825.839.434.2
C64Kidney382216.717.71621.221.68879638.60.014.721.80.0
C67Urinary bladder22316330.933.16022.724.1212464823271.225.530.127.19.9
C70-72Brain & nervous system753911.912.13632.032.2479126131.90.00.00.00.0
C73Thyroid1303147.249.09971.872.868171726291.363.648.019.10.0
C81Hodgkin lymphoma301857.159.01243.644.312378091.367.730.10.00.0
C82-85+C96Non-Hodgkin lymphoma29817920.221.011933.334.41185058561636.628.525.810.813.8
C91Lymphoid leukaemia704918.818.92123.823.955555025.20.00.00.015.4
C92-94Myeloid leukaemia1226011.611.8629.39.566142018414.28.115.30.00.0
C95Leukaemia unspecified43222119.019.62306868.80.00.00.00.0


Graphs:


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Chiang Mai, Thailand, 1993-1997 cases followed-up until 2000)
- Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Chiang Mai, Thailand, 1993-1997 cases followed-up until 2000)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Chiang Mai, Thailand, 1993-1997 cases followed-up until 2000)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Chiang Mai, Thailand, 1993-1997 cases followed-up until 2000)
- Table5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Chiang Mai, Thailand, 1993-1997)
- Table6: Comparison of 5-year absolute and relative survival of cases diagnosed between 1985-1992 and 1993-1997 (Chiang Mai, Thailand)
- Table6b: Comparison of 5-year absolute and relative survival of cases diagnosed between 1985-1992 and 1993-1997 (Chiang Mai, Thailand)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)